Termination Decision Document | Jul 13, 2018 | PAPER | BOARD |
2018-06-21 Joint Motion to Terminate | Jun 21, 2018 | PAPER | PATENT OWNER |
2018-06-21 Joint Request to File Settlement Agreement as Confidential | Jun 21, 2018 | PAPER | PATENT OWNER |
EX2093 (confidential) | Jun 21, 2018 | EXHIBIT | PATENT OWNER |
Trial Instituted Document | May 8, 2018 | PAPER | BOARD |
EX2002 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2006 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2009 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2014 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2016 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2030 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2031 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2033 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2034 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
2018-02-16 Patent Owner Preliminary Response IPR2018-00151 | Feb 16, 2018 | PAPER | PATENT OWNER |
EX2003 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2004 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2005 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2007 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2008 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2010 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2011 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2012 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2013 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2015 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2017 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2018 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2019 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2020 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2028 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2029 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2038 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2045 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2050 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2054 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2055 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2059 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2066 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2069 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2073 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2077 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2081 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2083 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2035 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2036 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2039 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2040 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2041 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2042 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2043 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2044 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2052 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2001 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2053 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2057 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2058 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2060 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2061 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2067 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2068 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2070 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2071 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2072 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2074 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2075 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2076 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2078 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2079 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2080 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2082 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2084 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2085 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2086 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2088 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2090 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2092 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2087 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2089 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
EX2091 | Feb 16, 2018 | EXHIBIT | PATENT OWNER |
Reply To Patent Owner's Opposition To Petitioner's Motion For Joinder | Jan 10, 2018 | PAPER | PETITIONER |
Ex. 1029 E-mail chain between Petitioners¿¿¿ and Patent Owner¿¿¿s Counsel re additional discovery | Jan 10, 2018 | EXHIBIT | PETITIONER |
Ex. 1030 Panacea US Certificate of Dissolution | Jan 10, 2018 | EXHIBIT | PETITIONER |
Ex. 1031 Panacea Biotech Annual Report 2016-2017 | Jan 10, 2018 | EXHIBIT | PETITIONER |
Petitioners' Updated Exhibit List | Jan 10, 2018 | PAPER | PETITIONER |
Patent Owner's Opposition to Joinder IPR2018-00151 | Dec 11, 2017 | PAPER | PATENT OWNER |
Mandatory Notice IPR2018-00151 | Nov 30, 2017 | PAPER | PATENT OWNER |
Notice of Accord Filing Date | Nov 16, 2017 | PAPER | BOARD |
Taxol label | Nov 9, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,498,421 | Nov 9, 2017 | EXHIBIT | PETITIONER |
Petitioners' Power Of Attorney | Nov 9, 2017 | PAPER | PETITIONER |
U.S. Patent No. 8,138,229 | Nov 9, 2017 | EXHIBIT | PETITIONER |
Declaration of Cory J. Berkland, Ph.D. | Nov 9, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,439,686 | Nov 9, 2017 | EXHIBIT | PETITIONER |
WO 2000/006152 | Nov 9, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,399,363 | Nov 9, 2017 | EXHIBIT | PETITIONER |
WO 1999/000113 | Nov 9, 2017 | EXHIBIT | PETITIONER |
Li et al., Fluorescein Binding to Normal Human Serum Proteins Demonstrated by Equilibrium Dialysis | Nov 9, 2017 | EXHIBIT | PETITIONER |
FDA Guideline on Sterile Drug Products Produced by Aseptic Processing | Nov 9, 2017 | EXHIBIT | PETITIONER |
EMEA Guidance on Manufacture of the Finished Dosage Form | Nov 9, 2017 | EXHIBIT | PETITIONER |
Elan Pharma Intl Ltd. v. Abraxis BioScience, Inc., Judgment and Verdict Form, | Nov 9, 2017 | EXHIBIT | PETITIONER |
Elan Pharma Intl Ltd. v. Abraxis BioScience, Inc., Sixth Day of Trial | Nov 9, 2017 | EXHIBIT | PETITIONER |
Elan Pharma Intl Ltd. v. Abraxis BioScience, Inc., Seventh Day of Trial | Nov 9, 2017 | EXHIBIT | PETITIONER |
Patient Information Leaflet, ABRAXANE for Injectable Suspension | Nov 9, 2017 | EXHIBIT | PETITIONER |
Administrative Documents, New Drug Application No. 21-660 | Nov 9, 2017 | EXHIBIT | PETITIONER |
Damascelli, B et al. Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI 007), | Nov 9, 2017 | EXHIBIT | PETITIONER |
Ibrahim et al., Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel | Nov 9, 2017 | EXHIBIT | PETITIONER |
U.S. Application No. 11/553,339, Non-Final Office Action (mailed Apr.
28, 2009) | Nov 9, 2017 | EXHIBIT | PETITIONER |
U.S. Application No. 11/553,339, Amendment in Response to Non-Final Office Action (dated Oct. 27, 2009) | Nov 9, 2017 | EXHIBIT | PETITIONER |
U.S. Application No. 11/553,339, Final Office Action (mailed Dec. 31, 2009) | Nov 9, 2017 | EXHIBIT | PETITIONER |
U.S. Application No. 11/553,339, Amendment After Final Action Under 37 C.F.R. 1.116 (dated Apr. 14, 2010) | Nov 9, 2017 | EXHIBIT | PETITIONER |
U.S. Application No. 11/553,339, Declaration of Neil P. Desai Pursuant to 37 C.F.R. 1.132 (dated Apr. 14, 2010) | Nov 9, 2017 | EXHIBIT | PETITIONER |
U.S. Application No. 11/553,339, Notice of Allowance and Fee(s) Due (mailed June 1, 2010) | Nov 9, 2017 | EXHIBIT | PETITIONER |
FDA, Approved Drug Products with Therapeutic Equivalence Evaluations | Nov 9, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,916,596 | Nov 9, 2017 | EXHIBIT | PETITIONER |
Remingtons Pharmaceutical Sciences (18th ed. 1990), Chapt. 85,
Intravenous Admixtures | Nov 9, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,177,460 | Nov 9, 2017 | EXHIBIT | PETITIONER |
Petitioners' Motion for Joinder Pursuant
to 35 U.S.C. ¿¿ 315(c) and 37 C.F.R. ¿¿¿¿ 42.22 & 42.122(b) | Nov 9, 2017 | PAPER | PETITIONER |
Petition For Inter Partes Review | Nov 9, 2017 | PAPER | PETITIONER |